Efficacy and safety of ramucirumab treatment in patients with advanced colorectal cancer: A protocol for systematic review and meta analysis

BACKGROUND: vascular endothelial growth factor receptor 2 (VEGFR-2) has an important role in colorectal cancer pathogenesis and progression. The aim of our study is to provide a protocol for assessing the efficacy and safety of ramucirumab (a monoclonal antibody VEGFR-2 antagonist) for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Man, Cheng, Honggang, Qu, Kai, Lu, Xiangqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302601/
https://www.ncbi.nlm.nih.gov/pubmed/32541497
http://dx.doi.org/10.1097/MD.0000000000020618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302601/
https://www.ncbi.nlm.nih.gov/pubmed/32541497
http://dx.doi.org/10.1097/MD.0000000000020618

Ejemplares similares